FDA and Poison Center Investigates Illnesses Linked to Edibles

Written by Kathrine Frich

Jun.18 - 2024 9:28 PM CET

Photo: Shutterstock
Photo: Shutterstock
Consumers are strongly advised against purchasing or consuming them

Trending Now

The FDA, in coordination with the CDC, America’s Poison Centers, and state and local health agencies, is actively investigating a series of illnesses associated with the consumption of Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies.

As of June 17, 2024, a total of 26 illnesses have been reported across 16 states. The affected individuals have experienced severe symptoms such as seizures, central nervous system depression, abnormal heart rates, and gastrointestinal distress.

Sixteen of those affected have required hospitalization, although no fatalities have been reported thus far.

Ongoing Analysis and Response Efforts

FDA and state partners have initiated sample collection and analysis of Diamond Shruumz-brand products to determine the cause of these illnesses.

The investigation is ongoing, focusing on identifying the specific contaminant or issue associated with these products.

Discussions with the manufacturer regarding a potential voluntary recall are currently underway, and the FDA continues to update its advisory as new information becomes available.

Consumers are strongly advised against purchasing or consuming any Diamond Shruumz-brand Chocolate Bars, Cones, or Gummies from any retail or online source until further notice.

Risks and Recommendations

Diamond Shruumz products are available for purchase both online and at various retail locations nationwide, including smoke/vape shops and stores that sell hemp-derived products like CBD or delta-8 THC.

Given the severity and variety of reported symptoms, the FDA emphasizes the importance of avoiding these products to prevent further illnesses.

Anyone who has recently purchased Diamond Shruumz-brand items should refrain from consuming them and consider disposing of them safely.

The FDA encourages individuals who have experienced symptoms potentially linked to these products to seek medical attention promptly and report their illness to local health authorities.